AzTrials
AzTrials

Rigid Bronchoscopy VentilationRBV-HFJVNCT07860918

Clinical Effects of Different Ventilation Strategies in Rigid Bronchoscopy Procedures

A study testing Jet Ventilation and Spontaneous Assisted Ventilation in people with Rigid Bronchoscopy Ventilation, run by The Affiliated Hospital of Qingdao University at 1 site in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study compares the effects of different ventilation strategies on patient safety and respiratory parameters during rigid bronchoscopy procedures. It enrolls patients undergoing the procedure at Qingdao University Affiliated Hospital, aiming to identify the optimal ventilation mode to reduce complications. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Rigid Bronchoscopy Ventilation
What is being tested?
Jet Ventilation and Spontaneous Assisted Ventilation
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteChina
Study dates
2 Oct 2026to 1 Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Patients scheduled for elective interventional rigid bronchoscopy, who agree to participate in this study and have no contraindications to anesthesia.

Who cannot join

  • History of allergic reaction to anesthetic agents;
  • Pregnancy;
  • Severe dysfunction of the heart, lung, liver, kidney or other vital organs;
  • Cognitive impairment or neurological diseases;
  • Contraindications to succinylcholine (e.g., hyperkalemia, extensive burns, severe trauma, crush injury, spinal cord injury, paraplegia, hemiplegia, myasthenia gravis, etc.); Refusal to participate in this study by the patient or their family members.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

China1 site, 1 recruiting
  • The Affiliated Hospital of Qingdao University

    Qingdao, Shangdong, 266000

    Xiangyu Ji, 17853298922, jixiangyu@qdu.edu.cn

    Recruiting

Other trials in China

About this study

This study compares the effects of different ventilation strategies on patient safety and respiratory parameters during rigid bronchoscopy procedures. It enrolls patients undergoing the procedure at Qingdao University Affiliated Hospital, aiming to identify the optimal ventilation mode to reduce complications.

Being tested
Jet Ventilation, Spontaneous Assisted Ventilation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Jet VentilationProcedure or surgery

    Jet ventilation delivered throughout rigid bronchoscopy procedure

  • Spontaneous Assisted VentilationProcedure or surgery

    Spontaneous assisted ventilation applied during rigid bronchoscopy to preserve patients' spontaneous breathing

Study groups in NCT07860918
Study groupRoleWhat they receive
Jet VentilationActive comparatorNot described
Receives: Procedure: Jet Ventilation
Spontaneous Assisted VentilationExperimentalNot described
Receives: Procedure: Spontaneous Assisted Ventilation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. peripheral oxygen saturation

    Use pulse oximetry to continuously monitor and record peripheral oxygen saturation (SpO₂) values throughout the study period, to evaluate the incidence and duration of hypoxemia.

    Measured: From enrollment to study completion, continuous monitoring during the entire observation period

Secondary outcomes (2)
  1. arterial blood pH

    Collect arterial blood pH values by arterial blood gas analysis to assess the acid-base status of subjects.

    Measured: Measurements will be performed 10 minutes after initiation of each respective ventilation mode.

  2. arterial partial pressure of carbon dioxide

    Collect arterial partial pressure of carbon dioxide (PaCO₂) via arterial blood gas analysis.

    Measured: 10 minutes after initiation of each ventilation mode

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2026
  2. Study start2 Oct 2026 (estimated)
  3. Primary completion31 May 2027 (estimated)
  4. Study completion1 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07860918
Sponsor's protocol ID
QYFYEC2026-254
Acronym
RBV-HFJV
Status last verified
Oct 2026
First submitted
1 Oct 2026
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Jet Ventilation and Spontaneous Assisted Ventilation in people with Rigid Bronchoscopy Ventilation, run by The Affiliated Hospital of Qingdao University at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Xiangyu Ji (17853298922, jixiangyu@qdu.edu.cn), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

peripheral oxygen saturation (time frame: From enrollment to study completion, continuous monitoring during the entire observation period). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in